UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000003753 |
|---|---|
| Receipt number | R000004431 |
| Scientific Title | the association of pancreatic fat content and various aspects of beta cell function |
| Date of disclosure of the study information | 2010/06/15 |
| Last modified on | 2010/06/14 22:25:37 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
the association of pancreatic fat content and various aspects of beta cell function
Acronym
the association of pancreatic fat content and various aspects of beta cell function
Scientific Title
the association of pancreatic fat content and various aspects of beta cell function
Scientific Title:Acronym
the association of pancreatic fat content and various aspects of beta cell function
Region
| Japan |
Condition
Condition
type 2 diabetes
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To measure pancreatic fat content by 1H-MRS, and examine the association of pancreatic fat and the state of glucose tolerance in Japanease type 2 diabetes.
Basic objectives2
Others
Basic objectives -Others
To clarify natural history of type 2 DM in Japanese
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
pancreatic fat content, measured by 1H-MRS
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
capable to be measured by MR imaging
Key exclusion criteria
1 Patients with contraindications for MR imaging and spectroscopy
(metallic implants, claustrophobia, pregnancy)
2 Patients who had history of pancreas operation
3 Other conditions precluding participation as judged by the investigator
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kazuhiko Sakaguchi |
Organization
Department of internal medicine, Kobe University Graduate School of medicine
Division name
Division of Diabetes and Endocrinology
Zip code
Address
7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
TEL
078-382-5861
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kazuhiko Sakaguchi |
Organization
Department of internal medicine, Kobe University Graduate School of medicine
Division name
Division of Diabetes and Endocrinology
Zip code
Address
7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
TEL
Homepage URL
Sponsor or person
Institute
Department of internal medicine, Kobe University Graduate School of medicine
Division of Diabetes and Endocrinology
Institute
Department
Personal name
Funding Source
Organization
entrusted accounting money
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2010 | Year | 06 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2010 | Year | 05 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2010 | Year | 05 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
compare between pancreas fat from PG and IRI
Management information
Registered date
| 2010 | Year | 06 | Month | 14 | Day |
Last modified on
| 2010 | Year | 06 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004431
